Back to your search result

Description

Application Notes: N-(5-Chloropyridin-2-yl)-N'-[(1S,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide-d6 or Edoxaban Impurity H-d6 is the labelled analogue of N-(5-Chloropyridin-2-yl)-N'-[(1S,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide (C380745) which is an impurity of Edoxaban (E555520). Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. Edoxaban Impurity H serves as a useful pharmaceutical standard. /// References: Ruff, C., et al.: Am. Heart J., 160, 635 (2010)| Ogata, K., et al.: J. Clin. Pharm., 50, 73 (2010)| Yoshino, T., et al.: Preparation of stereoisomers of N1-(5-chloropyridin-2-yl)-N2-[(1S, 2R, 4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide as pharmaceutical standards and as drugs for treating thrombosis, US Patent 20120053349, Mar 1, 2012|